MS Speaks

Abstract of a poster presentation at the annual ACTRIMS conference held in West Palm Beach, FL, February 24-26, 2022--"PML incidence rates in US patients treated with natalizumab: Update from the TOUCH program":


https://www.abstractsonline.com/pp8/#!/10495/presentation/255


It has been difficult to find data on the Tysabri-related PML cases.  The authors of this presentation are employees of Biogen, a fact that raises the suspicion that the data might be skewed in favor of Tysabri, but at least they are presenting some figures.